Dopamine-1-receptor stimulation and mucosal tissue oxygenation in the porcine jejunum
- 1 September 1995
- journal article
- laboratory investigation
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 23 (9) , 1560-1566
- https://doi.org/10.1097/00003246-199509000-00017
Abstract
Objective To evaluate the effects of dopamine-1-receptor stimulation on intestinal mucosal tissue oxygenation. Design Prospective, experimental, controlled trial. Setting Animal research laboratory. Subjects Anesthetized domestic pigs (30 to 45 kg). Interventions A small segment of the jejunal mucosa and serosa was exposed by midline laparotomy and antimesenteric incision. Fenoldopam, a selective dopamine-1-receptor agonist, was infused in steps, exponentially increasing from 0.6 to 9.6 micro gram /kg/min via a central venous catheter (n equals 8, fenoldopam group), whereas a second group (n equals 6, saline group) was only given the solvent. Measurements and Main Results Systemic hemodynamics as well as systemic and jejunal acid base and blood gas variables were measured using an arterial catheter, a thermodilution pulmonary artery catheter, and a jejunal venous catheter. Jejunal mucosal and serosal tissue PO2 were measured by means of Clark-type surface oxygen electrodes. Oxygen saturation and relative concentration of mucosal microvascular hemoglobin were measured by means of tissue reflectance spectrophotometry. In the fenoldopam group, systemic oxygen delivery (12.5 plus minus 0.8 mL/kg/min at baseline) increased by 56% (p less than .001) above baseline values. Mean arterial pressure remained unchanged. Fenoldopam produced a 51% increase in mucosal PO2 (23.8 plus minus 2.8 torr [3.2 plus minus 0.4 kPa] at baseline; p less than .001) and a 31% increase in mucosal hemoglobin oxygen saturation (55.4 plus minus 8.3% at baseline; p less than .001), but no change in serosal PO2 (58 plus minus 4.8 torr [7.7 plus minus 0.6 kPa] at baseline). Conclusions Fenoldopam improves tissue oxygenation of the porcine jejunum in a dose-related manner. This effect is limited to the inner mucosal layer. Dopamine-1-receptor agonists should be evaluated in patients presenting with signs of intestinal mucosal ischemia. (Crit Care Med 1995; 23:1560-1566)Keywords
This publication has 17 references indexed in Scilit:
- Sodium-taurocholate-induced acute necrotizing pancreatitis does not affect jejunal oxygenation in pigsCritical Care Medicine, 1994
- The Erlangen micro-lightguide spectrophotometer EMPHO IPhysics in Medicine & Biology, 1989
- The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in ratsEuropean Journal of Pharmacology, 1988
- An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride)The American Journal of Cardiology, 1988
- Endotoxemia and Bacteremia During Hemorrhagic Shock The Link Between Trauma and Sepsis?Annals of Surgery, 1988
- Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprussideAmerican Heart Journal, 1988
- The DA1 receptor agonist fenoldopam (SK & F 82526) is also an α2-adrenoceptor antagonistEuropean Journal of Pharmacology, 1985
- The effects of α- or β-adrenergic receptor agonists and antagonists and calcium entry blockers on the spontaneous vasomotionMicrovascular Research, 1984
- Dopamine produces vasolidation in specific regions and layers of the rabbit gastrointestinal tractLife Sciences, 1983
- Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic α2-adrenoceptorsEuropean Journal of Pharmacology, 1982